This study identified activation and migration mechanisms in CD4 + T-cells, as well as cholesterol uptake and biosynthesis, suggesting that defects we identified in peripheral blood CD4 + cells from RRMS patients compared with HCs are maintained and most likely elevated still further in CD4 + T-cells in the CSF. Here, CD4 is linked to relapsing-remitting multiple sclerosis.